Showing results (11-20 of 61) with videos related to
Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
Retrospective evaluation of the clinical and radiographic risk factors associated with severe pulmonary hemorrhage in first-line advanced, unresectable non-small-cell lung cancer treated with Carboplatin and Paclitaxel plus bevacizumabAlan B Sandler, Joan H Schiller, Robert Gray, et al.Lung Cancer (Amsterdam, Netherlands)|January 19, 2008
Phase II trial of gemcitabine/carboplatin followed by paclitaxel in patients with performance status=2,3 or other significant co-morbidity (HIV infection or s/p organ transplantation) in advanced non-small cell lung cancerBenjamin B Bridges, Leno Thomas, Petr F Hausner, et al.Cancer Research|February 21, 2006
C-fos assessment as a marker of anti-epidermal growth factor receptor effectAntonio Jimeno, Peter Kulesza, Erik Kincaid, et al.The New England Journal of Medicine|December 15, 2006
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancerAlan Sandler, Robert Gray, Michael C Perry, et al.European Journal of Cancer (Oxford, England : 1990)|August 14, 2018
Evaluation of health-related quality of life and symptoms in patients with advanced non-squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 057Martin Reck, Julie Brahmer, Bryan Bennett, et al.BMC Infectious Diseases|August 14, 2019
Pleural fluid secondary to pulmonary cryptococcal infection: a case report and review of the literatureYuan Zhang, Sean X Zhang, Julie Trivedi, et al.Pharmacoepidemiology and Drug Safety|January 11, 2016
Effectiveness of bevacizumab exposure beyond disease progression in patients with non-small-cell lung cancer: analyses of the ARIES observational cohort studyLarry Leon, Michael Kosty, Mohammad Jahanzeb, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 3, 2007
Imaging delta- and mu-opioid receptors by PET in lung carcinoma patientsIgal Madar, Badreddine Bencherif, Badredin Bencherif, et al.Cancer Chemotherapy and Pharmacology|April 2, 2008
Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumorsWells A Messersmith, Antonio Jimeno, David Ettinger, et al.RMD Open|September 12, 2022
Anti-RA33 antibodies are present in a subset of patients with immune checkpoint inhibitor-induced inflammatory arthritisLaura C Cappelli, Clifton O Bingham, Patrick M Forde, et al.Pageof 7